Polymer-assisted PD-L1 degradation and targeted photodynamic therapy synergize to suppress immunodeficient tumors
Checkpoint blockade immunotherapy has emerged as a transformative approach in cancer treatment by activating tumor-infiltrating T cells. However, the efficacy of PD-L1 blockade is restricted in “cold” tumors, which are characterized by low immunogenicity, presenting a challenge to immunotherapy. Thi...
Saved in:
| Main Authors: | Changyong Guo, Shipeng He, Huaxing Shen, Wei Cong, Jinqiu Li, Yajing Ji, Wenjing Huang, Fei Gao, Honggang Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525003296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
by: Changyong Guo, et al.
Published: (2025-01-01) -
PD-L1-targeted polymer-peptide-immune nanomedicine synergizes radiotherapy for durable tumor control
by: Jincheng Du, et al.
Published: (2025-09-01) -
An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer
by: Yuetong Liu, et al.
Published: (2025-07-01) -
Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer
by: Xiaobo Wang, et al.
Published: (2023-09-01) -
Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
by: Tao Xu, et al.
Published: (2025-04-01)